Home>About VRMNY>Our Physicians & Staff>Jason S. Slakter, MD
Our Physicians & Staff
Jason S. Slakter, MD
Jason S. Slakter, M.D., is a board certified vitreoretinal surgeon and macular disease specialist, and currently practices at the Vitreous–Retina–Macula Consultants in New York, N.Y. In addition, he is a Clinical Professor of Ophthalmology at New York University School of Medicine, and an attending surgeon and Surgeon Director at the Manhattan Eye, Ear and Throat Hospital in New York.
Dr. Slakter is a nationally and internationally recognized retinal specialist who has been involved in the design and application of a variety of diagnostic and therapeutic techniques. He has played a key role in the clinical development of digital indocyanine green angiography (ICG), particularly for the evaluation of macular degeneration and chorioretinal inflammatory disease. He has published more than 75 papers and book chapters. He also is an author of the first comprehensive text on the subject of ICG angiography.
Dr. Slakter’s chief research interests relate to the management of exudative age–related macular degeneration, retinal vascular disease and central serous chorioretinopathy. He has served as a principal investigator in the clinical trials of photodynamic therapy (PDT) with verteporfin and is currently conducting clinical studies for the treatment of central serous chorioretinopathy. He created and is the director of the Digital Angiography Reading Center, which serves as a key resource for numerous industry-sponsored studies, including the Anecortave Acetate for AMD clinical trials, trials evaluating the efficacy and safety of combining PDT with intravitreal triamcinolone acetonide, and numerous other anti-angiogenic compounds. He is on the medical advisory boards and serves as a consultant to many of the biotechnology and pharmaceutical companies involved in the development of new treatments for AMD, diabetic retinopathy and retinal vascular disease.
Dr. Slakter is a member of numerous medical organizations including The Macula Society, The Retina Society, and The American Society of Retina Specialists (formerly “The Vitreous Society”). He is the Editor–in–Chief of Retinal Physician, is on the editorial board of Retina and serves as a scientific reviewer for all of the major scientific ophthalmic journals.
Dr. Slakter is the recipient of many awards. In 1999, he received the American Academy of Ophthalmology Honor Award. He also has received The Macula Society’s Richard and Hinda Rosenthal Award for outstanding contribution to the treatment of ocular disease by an individual under the age of 45, as well as the Helen Keller Manhattan League Award in 2003. Dr. Slakter also received a Senior Honor Award from the American Academy of Ophthalmology at the 2004 annual meeting.